HCA · HCA Healthcare, Inc.

$382.21 +5.71 (+1.52%) At close · Jul 24

Market Cap

$84.78B

221.84M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue

$75.6B +7.1%

FY2025

Net Income

$6.78B +17.8%

FY2025

Diluted EPS

$28.33 +28.8%

FY2025

Operating Cash Flow

$12.64B +20.2%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenue	+7.9%	+8.0%	—	$77B – $79.5B	$76.39B	$75.6B^G	$70.6B	$64.97B	$60.23B	$58.75B	$51.53B	$51.34B	$46.68B	$43.61B	$41.49B	—	—	—	—	—	—	—
General & Administrative	+21.3%	+5.7%	+5.3%	—	$555M	$548M	$421M	$353M	$307M	$337M	$416M	$370M	$344M	$340M	$343M	$327M	$285M	$287M	$248M	$228M	$182M	$164M
Amortization of Intangibles	-35.2%	-14.3%	—	—	—	$12M	$16M	$20M	$44M	$25M	$26M	—	—	—	—	—	—	—	—	—	—	—
Depreciation & Amortization	+5.9%	+5.3%	+6.3%	—	$3.59B	$3.52B	$3.31B	$3.08B	$2.97B	$2.85B	$2.72B	$2.6B	$2.28B	$2.13B	$1.97B	$1.9B	$1.82B	$1.75B	$1.68B	$1.47B	$1.42B	$1.43B
Total Costs & Expenses	+8.4%	+7.4%	—	—	$66.6B	$65.77B	$62.08B	$57.26B	$51.65B	$48.92B	$46.1B	$46.09B	$41.34B	$39.23B	$36.68B	—	—	—	—	—	—	—
Interest Expense	+8.9%	+7.3%	+3.0%	—	$2.29B	$2.25B	$2.06B	$1.94B	$1.74B	$1.57B	$1.58B	$1.82B	$1.76B	$1.69B	$1.71B	$1.67B	$1.74B	$1.85B	$1.8B	$2.04B	$2.1B	$1.99B
Equity in Earnings of Unconsolidated Entities	+20.1%	+7.6%	+5.4%	—	$69M	$78M	$23M	$22M	$45M	$113M	$54M	$43M	$29M	$45M	$54M	$46M	$43M	$29M	$36M	$258M	$282M	$246M
Pretax Income	+4.6%	+12.6%	+9.5%	—	$9.79B	$9.83B	$8.52B	$7.71B	$8.58B	$9.83B	$5.43B	$5.24B	$5.34B	$4.38B	$4.81B	$3.96B	$3.48B	$2.95B	—	—	—	—
Income Tax	+5.5%	+14.5%	+5.0%	—	$1.98B	$2.05B	$1.87B	$1.62B	$1.75B	$2.11B	$1.04B	$1.1B	$946M	$1.64B	$1.38B	$1.26B	$1.11B	$950M	$888M	$719M	$658M	$627M
Net Income	+6.3%	+12.6%	+12.3%	—	$6.79B	$6.78B	$5.76B	$5.24B	$5.64B	$6.96B	$3.75B	$3.51B	$3.79B	$2.22B	$2.89B	$2.13B	$1.88B	$1.56B	$1.61B	$2.47B	$1.21B	$1.05B
Net Margin	—	—	—	—	—	8.97%	8.16%	8.07%	9.37%	11.84%	7.28%	6.83%	8.11%	5.08%	6.97%	—	—	—	—	—	—	—
Net Income Attributable to Noncontrolling Interests	-5.7%	+9.5%	+5.8%	—	$1.02B	$998M	$897M	$849M	$1.19B	$765M	$633M	$640M	$602M	$527M	$542M	$567M	$498M	$440M	$401M	$377M	$366M	$321M
Comprehensive Income	+7.3%	+13.1%	+12.1%	—	$6.82B	$6.87B	$5.8B	$5.31B	$5.56B	$7.05B	$3.71B	$3.43B	$3.78B	$2.28B	$2.82B	$2.19B	$1.81B	$1.76B	$1.59B	$2.45B	$1.23B	$1.21B
EPS (Basic) USD/shares	+13.9%	+20.9%	+18.8%	—	—	$28.70	$22.27	$19.25	$19.43	$21.52	$11.10	$10.27	$10.90	$6.12	$7.53	$5.14	$4.30	$3.50	$3.65	$5.17	$2.83	$2.48
EPS (Diluted) USD/shares	+13.9%	+21.0%	+19.0%	$28.70 – $30.50	—	$28.33^G	$22.00	$18.97	$19.15	$21.16	$10.93	$10.07	$10.66	$5.95	$7.30	$4.99	$4.16	$3.37	$3.49	$4.97	$2.76	$2.44
Shares Outstanding (Basic Avg) shares	-6.6%	-6.9%	-5.5%	—	—	236.41M	258.6M	272.4M	290.35M	323.32M	338.27M	341.21M	347.3M	362.31M	383.59M	414.19M	435.67M	445.07M	440.18M	476.61M	426.42M	425.57M
Shares Outstanding (Diluted Avg) shares	-6.7%	-7.0%	-5.6%	—	—	239.5M	261.81M	276.41M	294.67M	328.75M	343.61M	348.23M	355.3M	372.22M	395.85M	426.72M	450.35M	461.91M	459.4M	495.94M	437.35M	432.23M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2025: $49.09B in buybacks, $11.96B in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

1.73×

Medical Care Facilities median 1.26×

EV/EBIT

—

Medical Care Facilities median 19.44×

P/E (TTM)

13.17×

Medical Care Facilities median 15.43×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
American Group	$26,445,000,000	$24,668,000,000	$22,318,000,000	$20,858,000,000	$19,636,000,000	$23,593,000,000	$23,173,000,000	$21,959,000,000
Atlantic Group	$24,709,000,000	$23,380,000,000	$21,167,000,000	$19,324,000,000	$19,098,000,000	—	—	—
National Group	$21,278,000,000	$19,656,000,000	$18,105,000,000	$16,767,000,000	$16,329,000,000	$25,694,000,000	$25,913,000,000	$22,581,000,000
Corporate And Other	$3,168,000,000	$2,899,000,000	$3,378,000,000	$3,284,000,000	$3,689,000,000	$2,246,000,000	$2,250,000,000	$2,137,000,000

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Product And Service Other	$2,458,000,000	$2,542,000,000	$3,074,000,000	$3,514,000,000	$2,836,000,000	$1,875,000,000	$2,358,000,000	$1,965,000,000

Key facts CIK 860730 CUSIP 40412C101 13F (30d) 346 filings 342 filers Visit website Investor relations